Phio Pharmaceuticals (PHIO) EBT Margin (2012 - 2019)

Phio Pharmaceuticals (PHIO) has reported EBT Margin for 8 consecutive years, with 10219.05% the latest figure, recorded in Q1 2019.

• For the quarter ending Q1 2019, EBT Margin fell 48427.0% year-over-year to 10219.05%; the trailing twelve-month figure through Dec 2019 stood at 42795.24% (down 3746190.0% YoY), and the FY2019 full-year result was 42419.05%, down 3708571.0% from the prior year.
• EBT Margin retreated to 10219.05% in Q1 2019 per PHIO's latest filing, from 2619.3% in the prior quarter.
• Across five years, EBT Margin topped out at 2619.3% in Q3 2018 and bottomed at 24577.78% in Q2 2016.
• Historically, EBT Margin has averaged 11843.37% across 5 years, with a median of 9976.92% in 2018.
• The sharpest annual moves came in 2016 and 2019: EBT Margin plunged 1364824 bps in 2016, then tumbled 48427 bps in 2019.
• Over 5 years, EBT Margin stood at 8661.76% in 2015, then slumped by 184 bps to 24577.78% in 2016, then jumped by 46 bps to 13346.67% in 2017, then soared by 80 bps to 2619.3% in 2018, then slumped by 290 bps to 10219.05% in 2019.
• According to Business Quant data, EBT Margin over the past three periods registered 10219.05%, 2619.3%, and 3277.59% for Q1 2019, Q3 2018, and Q2 2018 respectively.